CMMB
Chemomab Therapeutics
CMMB
CMMB
8 hedge funds and large institutions have $3.11M invested in Chemomab Therapeutics in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
8
Holders Change
+8
Holders Change %
–
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
KCM
1
Kennedy Capital Management
St Louis,
Missouri
| $1.36M | 200,000 | +200,000 | New |
|
|
AIC
2
AWM Investment Company
New York
| $679K | 100,000 | +100,000 | New |
|
|
RI
3
RTW Investments
New York
| $411K | 60,414 | +60,414 | New |
|
4
Fidelity Investments
Boston,
Massachusetts
| $288K | 43,000 | +43,000 | New |
|
|
MIH
5
Meitav Investment House
Bene-Beraq,
Israel
| $177K | 26,087 | +26,087 | New |
|
|
DG
6
Delek Group
Herzliya,
Israel
| $176K | 26,087 | +26,087 | New |
|
7
UBS Group
Zurich,
Switzerland
| $19K | 2,735 | +2,735 | New |
|
|
CCA
8
Catalyst Capital Advisors
Huntington,
New York
| $3K | 500 | +500 | New |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|